Claims
- 1. A compound of formula (1): ##STR62## wherein R.sub.1 is selected from (i) phenyl, phenyl substituted by one or more radical (s) selected from the group consisting of halogen, branched or linear (C.sub.1 -C.sub.7) alkyl, (C.sub.1 -C.sub.7)acyl, trifluoromethyl, (C.sub.1 -C.sub.7)-alkoxy, (C.sub.1 -C.sub.7)alkylsulfonyl, trifluoromethoxy, nitro, cyano, (C.sub.1 -C.sub.7)cycloalkyl, phenyl, (C.sub.1 -C.sub.7)alkylthio, amino, (C.sub.1 -C.sub.7)alkylsulfinyl, hydroxy and acetamido, (iii) naphtyl, (iv) dimethylaminonaphtyl, (v) thienyl, (vi) chlorothienyl, (vii) furyl, (viii) imidazolyl, (ix) quinolyl and (x) methylquinolyl;
- R.sub.2 and R.sub.3 are different; one of the two represents W, the other is selected from the group consisting of hydrogen, halogen, trifluoromethyl, (C.sub.1 -C.sub.7)alkyl, (C.sub.3 -C.sub.12)cycloalkyl, (C.sub.1 -C.sub.7)alkoxy, (C.sub.1 -C.sub.7)alkylthio, (C.sub.1 -C.sub.7)alkylsulfinyl, (C.sub.1 -C.sub.7)alkylsulfonyl, (C.sub.1 -C.sub.7)acyl, (C.sub.1 -C.sub.7)thioacyl, hydroxy, amino (C.sub.1 -C.sub.7)alkyl substituted amino, di-(C.sub.1 -C.sub.7)alkyl substituted amino, nitro, nitrile, and azide;
- W is a group --Z--Ar--(CH.sub.2).sub.q --A in which A is selected from --CO.sub.2 H, --SO.sub.3 H, --PO.sub.3 H, --CO.sub.2 Et, --CO.sub.3 Me, hydroxyl, carboxyethylaminocarbonyl, carboxyethylcarbonyl, --CONH.sub.2, diethylaminoethylcarbonyl, carboxyethylcarbonyl, morpholinocarbonyl, tetrazolyl, 4,5-dihydro-3-oxo[2H]pyridazinyl and COCH.sub.3 ;
- q is selected from 0, 1, 2, 3 and 4; Ar represents phenyl; Z is selected from oxygen, methylene and a bond;
- R.sub.4, R.sub.5 and R.sub.6 independently have the meaning of R.sub.2 or R.sub.3, except W;
- Y is a group --(CH.sub.2).sub.s --B--(CH.sub.2).sub.t ; s and t are each independently selected from 0, 1 and 2; B is selected from oxygen, carbonyl, --C(Me).sub.2 and a bond; n is selected from 0 and 1;
- a physiologically acceptable salt thereof, a physiologically acceptable salt in the form of a complex thereof, a physiologically acceptable complex thereof, a physiologically acceptable ester thereof or a physiologically acceptable amide thereof.
- 2. The compound of claim 1, wherein R.sub.3 is a group W and R is different from W.
- 3. The compound of claim 1, wherein R.sub.2 is W, and R.sub.3 is different from W.
- 4. The compound of claim 1, wherein R.sub.3 is a group W, and Z contained in W is an atom of oxygen.
- 5. The compound of claim 1, wherein R.sub.2 is W, and Z contained in W is a bond.
- 6. The compound of claim 1, selected from the group consisting of trans-4-[[2-[[(4-chlorophenyl)sulfonyl]amino]cyclopentyl]methyl]-benzeneacetic acid, trans -4-[[2-[[(4-chlorophenyl)sulfonyl]amino]cyclohexyl]methyl]benzeneacetic acid, cis-4-[[2-[[(4-chlorophenyl)sulfonyl]amino]cyclopentyl]methyl]benzeneacetic acid.
- 7. The compound of claim 1, consisting of 4-[2-[[(4-chlorophenyl)sulfonyl]amino]cyclopentyloxy]benzeneacetic acid.
- 8. The compound of claim 1, selected from the group consisting of 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-methylphenyl)sulfonyl]amino]methyl]cyclopentyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-bromophenyl)sulfonyl]amino]methyl]cyclopentyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-chloro-2-fluorophenyl)sulfonyl]amino]methyl]cyclopentyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopropyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclobutyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-bromophenyl)sulfonyl]amino]methyl]cyclobutyl]methyl]benzeneacetic acid, 4-[[1-[[[(4-chlorophenyl]sulfonyl]amino]methyl ]-3,3-dimethylcyclobutyl]methyl]benzeneacetic acid.
- 9. The compound of claim 1, selected from the group consisting of 4-[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl]benzeneacetic acid, 4-[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclobutyl]benzeneacetic acid, 4-[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopropyl]benzeneacetic acid.
- 10. Medicine containing as active ingredient an efficient quantity of at least one compound described in claim 1, in association with a pharmaceutically acceptable carrier.
- 11. A compound according to claim 1, in which R.sub.2 and R.sub.3 are different, one of the two representing W, the other being selected from the group consisting of hydrogen and (C.sub.1 -C.sub.7)alkyl.
- 12. A compound of formula (1): ##STR63## wherein R.sub.1 is selected from (i) phenyl, (ii) phenyl substituted by one or more radical (s) selected from the group consisting of halogen, branched or linear (C.sub.1 -C.sub.7)alkyl, (C.sub.1 -.sub.7)acyl, trifluoromethyl, (C.sub.1 -C.sub.7)-alkoxy, methylsulfonyl, trifluoromethoxy, nitro, cyano, cyclohexyl, phenyl, methylthio, amino, methylsulfinyl, hydroxy and acetamido, (iii) naphtyl, (iv) dimethylaminoaphtyl, (v) thienyl, (vi) chlorothienyl, (vii) furyl, (viii) imidazolyl, (ix) quinolyl and (x) methylquinolyl;
- R.sub.2 and R.sub.3 are different; one of the two represents W, the other is selected from the group consisting of hydrogen, halogen, trifluoromethyl, (C.sub.1 -C.sub.7)alkyl, (C.sub.3 -C.sub.12)cycloalkyl, (C.sub.1 -C.sub.7)alkoxy, (C.sub.1 -C.sub.7)alkylthio, (C.sub.1 -C.sub.7)alkylsulfinyl, (C.sub.1 -C.sub.7)alkylsulfonyl, (C.sub.1 -C.sub.7)acyl, (C.sub.1 -C.sub.7)thioacyl, hydroxy, amino, (C.sub.1 -C.sub.7)alkyl substituted amino, di- (C.sub.1 -C.sub.7)alkyl substituted amino, nitro, nitrile and azide;
- W is a group --Z--Ar--(CH.sub.2).sub.q --A in which A is selected from --CO.sub.2 H, --SO.sub.3 H, --PO.sub.3 H.sub.2, --CO.sub.2 Et, --CO.sub.2 Me, hydroxyl, carboxyethylaminocarbonyl, carboxyethylcarbonyl, --CONH.sub.2, diethylaminoethylcarbonyl, carboxyethylcarbonyl, morpholinocarbonyl, tetrazolyl, 4,5-dihydro-3-oxo[2H]pyridazinyl and COCH.sub.3 ;
- q is selected from 0, 1, 2; Ar represents phenyl; Z is selected from oxygen, methylene and a bond;
- R.sub.4, R.sub.5 and R.sub.6 independently have the meaning of R.sub.2 or R.sub.3, except W;
- Y is a group --(CH.sub.2).sub.s --B--(CH.sub.2).sub.t ; s and t are each independently selected from 0, 1 and 2; B is selected from oxygen, carbonyl, --C(Me).sub.2 and a bond; n is selected from 0 and 1; a physiologically acceptable salt thereof, a physiologically acceptable salt in the form of a complex thereof, a physiologically acceptable complex thereof, a physiologically acceptable ester thereof, or a physiologically acceptable amide thereof.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9009737 |
Jul 1990 |
FRX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/736,240, filed on Jul. 26, 1991, now abandoned.
US Referenced Citations (5)
Foreign Referenced Citations (3)
Number |
Date |
Country |
0312906 |
Apr 1989 |
EPX |
0358398 |
Mar 1990 |
EPX |
0361113 |
Apr 1990 |
EPX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
736240 |
Jul 1991 |
|